Kolexia
Flet Laurent Pharmacien
Flet Laurent
Pharmacien
Hôpital Hôtel-Dieu Nantes
Nantes, France
81 Activités
366 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Pneumopathie infectieuse COVID-19 Lésions encéphaliques Obésité Lésions traumatiques de l'encéphale Traumatismes cranioencéphaliques Insulinorésistance Dyslipidémies Polytraumatisme

Collaborateurs

Voir plus
Roquilly Antoine
Roquilly Antoine
Hôpital Hôtel-Dieu Nantes, Nantes, France
Asehnoune Karim
Asehnoune Karim
Hôpital Hôtel-Dieu Nantes, Nantes, France
Chiffoleau Anne
Chiffoleau Anne
Hôpital Hôtel-Dieu Nantes, Nantes, France
Mahe Pierre-Joachim
Mahe Pierre-Joachim
Hôpital Hôtel-Dieu Nantes, Nantes, France

Industries

Voir plus
ViiV Healthcare
3 collaboration(s)
Dernière en 2023
Janssen
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
PCSK9 inhibition protects mice from food allergy
Translational research : the journal of laboratory and clinical medicine   11 mars 2024
Efficacy of Spironolactone Compared with Doxycycline in Moderate Acne in Adult Females: Results of the Multicentre, Controlled, Randomized, Double-blind Prospective and Parallel Female Acne Spironolactone vs doxyCycline Efficacy (FASCE) Study.
Acta dermato-venereologica   21 février 2024
PROPERTY: Randomized, Double-blind, Multicenter Placebo-controlled Study Evaluating Neurotoxicity in Patients With Metastatic Gastro Intestinal Cancer Taking Phycocare® or Placebo During Oxaliplatin Based Chemotherapy
Essai Clinique (Algosource)   05 octobre 2023
FASCE: Randomized Double-blind Study on the Benefit of Spironolactone for Treating Acne of Adult Woman.
Essai Clinique (CHU Nantes)   17 juillet 2023
Analysis of cost-effectiveness of chemotherapeutic agents and new therapies for the management of unresectable and metastatic melanoma.
European journal of dermatology : EJD   12 juillet 2023
POCA: Prospective Multicenter Randomized Controlled Double-blind Label Study of the Prophylaxis of Recurrent Pouchitis After Fecal Microbiota Transplant in UC With Ileo-anal Anastomosis
Essai Clinique (CHU Nantes)   14 juin 2023
Use of artesunate in the treatment of severe imported malaria in France: review of the effectiveness and real-life safety in two French university hospitals.
BMC infectious diseases   25 mai 2023
Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial.
Intensive care medicine   18 avril 2023
PROPERTY: study protocol for a randomized, double-blind, multicenter placebo-controlled trial assessing neurotoxicity in patients with metastatic gastrointestinal cancer taking PHYCOCARE® during oxaliplatin-based chemotherapy.
Trials   20 janvier 2023
Treatment of nonarteritic anterior ischemic optic neuropathy with an endothelin antagonist: ENDOTHELION (ENDOTHELin antagonist receptor in Ischemic Optic Neuropathy)-a multicentre randomised controlled trial protocol.
Trials   29 octobre 2022